Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore! Learn More →

← Back to all trials

Recruiting NCT05664555

Low Dose Fluorescein Angiography Comparing 1mL and 3mL of 10% Fluorescein

Conditions: Retinal Disease

Sex: All

Ages: 19 Years – N/A

Phase: PHASE4

Enrollment: 144

Sponsor: Seoul National University Bundang Hospital

Location: Korea, Republic of

Summary

This study aims to compare the efficacy and safety of fluorescein angiography using 1mL versus 3mL of 10% fluorescein dye.

Eligibility Criteria

Inclusion Criteria:Patients who required an fluorescein angiography for their retinal diseases (eg. diabetic retinopathy, retinal vein occlusion, etc.)Exclusion Criteria:media opacity (corneal opacity, vitreous hemorrhage grade 2 or more, cataract LOCS III grade 3 or more)known history of adverse reactions to fluoresceindilated pupil diameter less than 5 mm

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05664555). StuddyBuddy aggregates publicly available trial information.